Shire’s Bet on NPS Pharma Pays Off with Natpara® Approval

By Heather Cartwright

Pharma Deals Review: Vol 2015 Issue 2 (Table of Contents)

Published: 3 Feb-2015

DOI: 10.3833/pdr.v2015.i2.2091     ISSN: 1756-7874

Section: Mergers & Acquisitions



Shire’s decision to buy rare disease specialist NPS Pharmaceuticals for approximately US$5...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details